drugset / Trial / NCT05549323

A Study to Learn About the Safety, Effects and Pharmacokinetics of Study Medication (PF-07054894) for the Treatment of Ulcerative Colitis

NCT05549323 ↗

Phase 1 Terminated 44 enrolled Pfizer
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a study to learn if the experimental medicine (called PF-07054894) is safe, effective, and how it is processed in adult people with ulcers in the colon.

Timeline

Start
2022-11-07
Primary completion
2025-11-11
Completion
2025-11-11

Outcome

Outcome not reported

Stopped (Business): “The study was terminated due to business decision. The decision to terminate the trial was not based on any safety concerns associated with PF-07054894.”

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-07054894 Small molecule — Oral

Indications